Filing Details

Accession Number:
0001104659-24-025520
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-20 16:11:20
Reporting Period:
2024-02-20
Accepted Time:
2024-02-20 16:11:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1425205 Iovance Biotherapeutics Inc. IOVA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1423102 P. Wayne Rothbaum C/O Iovance Biotherapeutics, Inc.
825 Industrial Road, 4Th Floor
San Carlos CA 94070
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-02-20 5,000,000 $9.15 28,067,333 No 4 P Indirect By Quogue Capital LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Quogue Capital LLC
Footnotes
  1. Such shares may be held directly by Quogue Capital LLC or are held by one or more entities controlled by Quogue Capital LLC. The reporting person is the sole managing member of Quogue Capital LLC, and therefore, he is deemed to beneficially own such shares of common stock of the Issuer.
  2. The numbers reported in column 5 exclude 1,932,667 shares of common stock underlying 1,932,667 shares of Series B Preferred Stock of the Issuer beneficially owned by Quogue Capital LLC.
  3. Such shares purchased pursuant to Issuer's underwritten offering, which priced on 02/20/2024.